• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型牛心包生物假体主动脉瓣置换术的五年随访结果

Five-year outcomes of surgical aortic valve replacement with a novel bovine pericardial bioprosthesis.

作者信息

Chen Jinmiao, Lv Minzhi, Fu Jiahui, He Chen, Guo Yingqiang, Tao Liang, Zhou Xinmin, Gu Tianxiang, Bartus Krzysztof, Wei Lai, Hong Tao, Wang Chunsheng

机构信息

Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.

Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Interdiscip Cardiovasc Thorac Surg. 2024 Jan 2;38(1). doi: 10.1093/icvts/ivad209.

DOI:10.1093/icvts/ivad209
PMID:38180879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10781661/
Abstract

OBJECTIVES

The short-term performance of the Cingular bovine pericardial aortic valve was proven. This study evaluated its 5-year safety and haemodynamic outcomes.

METHODS

It enrolled 148 patients who underwent surgical aortic valve replacement with the Cingular bovine pericardial aortic valve between March 2016 and October 2017 in 5 clinical centres in China. Safety and haemodynamic outcomes were followed up to 5 years. The incidence of all-cause mortality, structural valve deterioration and reintervention was estimated by Kaplan-Meier analysis.

RESULTS

The mean age of patients was 67.7 [standard deviation (SD) 5.1] years, and 36.5% of patients were female. The mean follow-up was 5.3 (SD 1.2) years. Five-year freedom from all-cause mortality, structural valve deterioration and all-cause reintervention were 91.2%, 100% and 99.3%, respectively. At 5 years, the mean gradient and effective orifice area of all sizes combined were 14.0 (SD 5.5) mmHg and 1.9 (SD 0.3) cm2, respectively. For 19- and 21-mm sizes of aortic prostheses, the mean gradients and effective orifice area at 5 years were 17.5 (SD 7.0) mmHg and 1.6 (SD 0.2) cm2 and 13.7 (SD 6.7) mmHg and 1.8 (SD 0.3) cm2, respectively. The incidence of moderate or severe patient-prosthesis mismatch was 4.1% and 0.0% patients at 5 years, respectively.

CONCLUSIONS

The 5-year safety and haemodynamic outcomes of Cingular bovine pericardial aortic valve are encouraging. Longer-term follow-up is warranted to assess its true durability.

摘要

目的

已证实Cingular牛心包主动脉瓣的短期性能。本研究评估了其5年安全性和血流动力学结果。

方法

纳入2016年3月至2017年10月在中国5个临床中心接受Cingular牛心包主动脉瓣置换术的148例患者。对安全性和血流动力学结果进行了长达5年的随访。采用Kaplan-Meier分析估计全因死亡率、瓣膜结构恶化和再次干预的发生率。

结果

患者的平均年龄为67.7岁[标准差(SD)5.1],36.5%为女性。平均随访时间为5.3年(SD 1.2)。全因死亡率、瓣膜结构恶化和全因再次干预的5年无事件生存率分别为91.2%、100%和99.3%。5年时,所有尺寸组合的平均压差和有效瓣口面积分别为14.0(SD 5.5)mmHg和1.9(SD 0.3)cm²。对于19毫米和21毫米尺寸的主动脉假体,5年时的平均压差和有效瓣口面积分别为17.5(SD 7.0)mmHg和1.6(SD 0.2)cm²以及13.7(SD 6.7)mmHg和1.8(SD 0.3)cm²。5年时中度或重度人工瓣膜-患者不匹配的发生率分别为4.1%和0.0%。

结论

Cingular牛心包主动脉瓣的5年安全性和血流动力学结果令人鼓舞。有必要进行长期随访以评估其真正的耐久性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800c/10781661/3a9c3b0b709c/ivad209f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800c/10781661/87dc24aa27e3/ivad209f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800c/10781661/eefa4f2cc194/ivad209f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800c/10781661/d6f0f117036f/ivad209f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800c/10781661/3a9c3b0b709c/ivad209f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800c/10781661/87dc24aa27e3/ivad209f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800c/10781661/eefa4f2cc194/ivad209f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800c/10781661/d6f0f117036f/ivad209f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800c/10781661/3a9c3b0b709c/ivad209f3.jpg

相似文献

1
Five-year outcomes of surgical aortic valve replacement with a novel bovine pericardial bioprosthesis.新型牛心包生物假体主动脉瓣置换术的五年随访结果
Interdiscip Cardiovasc Thorac Surg. 2024 Jan 2;38(1). doi: 10.1093/icvts/ivad209.
2
One-year outcome with a bovine pericardial valve.牛心包瓣膜的一年期结果。
JTCVS Open. 2020 Apr 21;2:1-11. doi: 10.1016/j.xjon.2020.04.002. eCollection 2020 Jun.
3
Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes.带支架心包生物瓣的主动脉瓣置换术:5 年结果。
Eur J Cardiothorac Surg. 2022 Aug 3;62(3). doi: 10.1093/ejcts/ezac374.
4
Two-Year Clinical Follow-Up Assessment of the Novel Cingular Surgical Bovine Pericardial Valve.新型带环牛心包瓣膜的两年临床随访评估
Front Cardiovasc Med. 2021 Dec 13;8:736877. doi: 10.3389/fcvm.2021.736877. eCollection 2021.
5
Safety, efficacy, and hemodynamic performance of a stented bovine pericardial aortic valve bioprosthesis: Two-year analysis.支架牛心包主动脉瓣生物假体的安全性、疗效和血液动力学性能:两年分析。
J Thorac Cardiovasc Surg. 2020 Aug;160(2):371-381.e4. doi: 10.1016/j.jtcvs.2019.07.132. Epub 2019 Sep 9.
6
[Mosaic bioprosthesis after 5 years].[5年后的镶嵌式生物假体]
Herz. 2000 Nov;25(7):659-66. doi: 10.1007/pl00001980.
7
Durability of a bovine pericardial aortic bioprosthesis based on Valve Academic Research Consortium-3 echocardiographic criteria.基于瓣膜学术研究联盟-3超声心动图标准的牛心包主动脉生物假体的耐久性
JTCVS Open. 2022 May 29;11:72-80. doi: 10.1016/j.xjon.2022.05.008. eCollection 2022 Sep.
8
Clinical and haemodynamic outcomes in 804 patients receiving the Freedom SOLO stentless aortic valve: results from an international prospective multicentre study.804例接受Freedom SOLO无支架主动脉瓣膜患者的临床和血流动力学结果:一项国际前瞻性多中心研究的结果
Eur J Cardiothorac Surg. 2015 Mar;47(3):e97-104. doi: 10.1093/ejcts/ezu471. Epub 2014 Dec 13.
9
Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial.水仙™主动脉和二尖瓣心包生物假体的临床结果及血流动力学表现:来自水仙-1首次人体试验的1年结果
J Cardiothorac Surg. 2020 Jun 15;15(1):140. doi: 10.1186/s13019-020-01154-7.
10
[Clinical and hemodynamic results of the mosaic bioprosthesis in aortic position].[主动脉位置镶嵌式生物假体的临床及血流动力学结果]
Z Kardiol. 2003 May;92(5):407-14. doi: 10.1007/s00392-003-0927-2.

本文引用的文献

1
Structural hemodynamic valve deterioration durability of RESILIA-tissue versus contemporary aortic bioprostheses.RESILIA 组织与当代主动脉生物瓣的结构性血流动力学瓣膜退变耐久性比较。
J Comp Eff Res. 2023 Mar;12(3):e220180. doi: 10.2217/cer-2022-0180. Epub 2023 Jan 23.
2
One-year outcome with a bovine pericardial valve.牛心包瓣膜的一年期结果。
JTCVS Open. 2020 Apr 21;2:1-11. doi: 10.1016/j.xjon.2020.04.002. eCollection 2020 Jun.
3
Commentary: It looks good, but will it last?评论:看起来不错,但能持久吗?
JTCVS Open. 2020 May 1;2:12-13. doi: 10.1016/j.xjon.2020.04.004. eCollection 2020 Jun.
4
Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes.带支架心包生物瓣的主动脉瓣置换术:5 年结果。
Eur J Cardiothorac Surg. 2022 Aug 3;62(3). doi: 10.1093/ejcts/ezac374.
5
"Roof" technique-a modified aortotomy closure in Y-incision aortic root enlargement upsizing 3-4 valve sizes.“屋顶”技术——Y形切口主动脉根部扩大术中改良的主动脉切开术缝合,扩大3-4个瓣膜尺寸。
JTCVS Tech. 2022 Jan 26;12:33-36. doi: 10.1016/j.xjtc.2022.01.006. eCollection 2022 Apr.
6
Prosthesis-patient mismatch following aortic and mitral valves replacement - A comprehensive review.主动脉瓣和二尖瓣置换术后假体-患者不匹配:全面综述。
Prog Cardiovasc Dis. 2022 May-Jun;72:84-92. doi: 10.1016/j.pcad.2022.02.004. Epub 2022 Feb 27.
7
Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement With RESILIA Tissue.RESILIA 组织补片行主动脉瓣置换术的 COMMENCE 试验的 5 年结果。
Ann Thorac Surg. 2023 Jun;115(6):1429-1436. doi: 10.1016/j.athoracsur.2021.12.058. Epub 2022 Jan 20.
8
Two-Year Clinical Follow-Up Assessment of the Novel Cingular Surgical Bovine Pericardial Valve.新型带环牛心包瓣膜的两年临床随访评估
Front Cardiovasc Med. 2021 Dec 13;8:736877. doi: 10.3389/fcvm.2021.736877. eCollection 2021.
9
2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020年美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Thorac Cardiovasc Surg. 2021 Aug;162(2):e183-e353. doi: 10.1016/j.jtcvs.2021.04.002. Epub 2021 May 8.
10
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.瓣膜学术研究联合会 3 期:主动脉瓣临床研究更新的终点定义。
Eur Heart J. 2021 May 14;42(19):1825-1857. doi: 10.1093/eurheartj/ehaa799.